ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Sihuan Pharmaceutical (0460.HK) receives approval for its exclusive medical aesthetic product Letybo (botulinum toxin), A blockbuster product in a hundred-billion size market
October 28, 2020Sihuan Pharmaceutical Holdings Group Ltd. is pleased announce that "Type A Botulinum Toxin for Injection" (Letybo 100U), a product exclusively distributed by Sihuan Pharmaceutical, has officially received the marketing approval from the ... -
People With Movement Disorders May Become Immune to Botox Therapy
December 29, 2018Some people who receive botulinum toxin injections for disorders that cause muscle tightness and contractions develop resistance to the treatment, researchers say.
Pharma Sources Insight January 2025
